Brief: China Resources Pharmaceutical Says 9M Net Profit For CR Boya Bio-Pharmaceutical At RMB343 Million
27/10/2025 12:15
Oct 27 (Reuters) - China Resources Boya Bio pharmaceutical Group Co Ltd 300294.SZ: 9M NET PROFIT FOR CR BOYA BIO-PHARMACEUTICAL RMB343 MILLION 9M CR BOYA BIO-PHARMACEUTICAL REVENUE RMB1.47 BILLION Further company coverage: 300294.SZ ((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals
Brief: China Resources Pharmaceutical Says CR Boya Bio-Pharmaceutical Posts Quarterly Unaudited Revenue RMB 321.1 Million, Net Profit RMB 30.0 Million